News June 2004
The smell of death
Volatile metabolites provide vital clues in murder investigation.
Argenta set to license oncology programme
Argenta's oncology programme is now ready for licensing and the company is 'having serious conversations' over this with several companies.
Nano-engineering crystal arrays
Materials chemists in the UK have made important advances in understanding how to control the growth of films of zinc oxide crystals on a range of substrates.
Opening the access debate
The final evidence session of the House of Commons Science and Technology Committee inquiry into scientific publishing has exposed wide gaps in the understanding of issues surround...
Emissions trading goes global
Emission reduction worldwide will count towards EU credits.
Sanofi-Aventis emerges
Aventis has finally accepted a bid from its French rival Sanofi Synthélabo.
Publishing on the edge
With moments to spare before the official launch, the Royal Society has published the first paper in its new journal dedicated to research at the physical-life science interface.
Skyepharma - down but not out
Rumours of an enforced exodus among senior management at SkyePharma.
Biotech report fails to impress industry
EU biotechnology strategy reports limited progress.
Beware the 'lucrative' research grant
Academic researchers world-wide need to get up to speed with ongoing changes to patent legislation or face potentially grave financial consequences.
Ionic liquids: what the Heck is the promise?
Ionic liquids (ILs) are often hailed as the green saviours of organic chemistry.
Reaching for an opportunity
The UK chemical industry should see the impending Registration, Evaluation and Authorisation of Chemicals (Reach) legislation as 'an opportunity, not a threat'.
Chemical concerns for MEPs
Being a member of the European Parliament (MEP) could be a risky occupation.
EU sets limits for pesticides in food
Judging by the workload facing the new European Food Safety Authority (EFSA), a move to Europe could be a smart decision for scientists looking for long-term job security.
Superbug buster
The publication of results using a novel bio-decontamination technique has pumped up the share price of the British company that developed the technology and could advance the figh...
Fire at Acordis plant
Fire investigators are probing the cause of a blaze at a chemical plant in Derby, UK.
Rising interest in cholesterol reduction
Billion dollar sales set for a shake up.
Just an accident?
A second inquest into the death of a British serviceman involved in nerve agent trials at Porton Down fifty years ago began on 5 May 2004.

Chemical bounty in the bargain basement
The Chemical Heritage Foundation (CHF), Philadelphia, US, has acquired a priceless collection of textbooks chronicling the past 600 years of chemistry.
Detecting pathogens on a micro-scale
US researchers develop portable genetic analysis device.
Crystals go under cover
Fooling the human body by camouflaging inorganic particles as proteins.
Protein target for natural cancer treatment
Enzyme holds key to anti-cancer properties of bacterial product.
Spicing up a cystic fibrosis solution
Opening therapeutic options for lung disease.

